YOLFTbeta
NeutriSci International Inc

NeutriSci International Inc

NU · V · Healthcare / Drug Manufacturers - Specialty & Generic

12.32CAD+0.29 (+2.41%)

Price History

Full chart

Market Stats

Previous Close12.03
Open12.20
Day Range12.07 – 12.35
52-Week Range11.20 – 18.98
Volume57.73M
Market Cap892.12K
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.82
50-Day Avg0.0052
200-Day Avg0.0056

About

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Glen Rehman
  • Employees0
  • Headquarters1600 ? 609 Granville Street, Vancouver, BC, Canada, V7Y 1C3, Canada
  • Websitehttps://www.neutrisci.com

Leadership

  • Mr. Glen RehmanCEO, President & Director
  • Mr. John Robert ChisholmChief Financial Officer · b. 1962
  • Ms. Jaycee WatersOperations & Logistics Manager
  • Mr. Thierry SorhaitzVice President of Sales & Marketing

Financials

Income Statement

Currency: CAD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-09-302014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Revenue4.48K2.39K1.99K101.44K61.99K390.07K630.46K311.42K488.17K218.48K274.80K--249.42K027.79K125.35K151.07K82.66K96.54K74.57K80.89K457.75K59.98K
Growth (%)--46.74%-16.47%+4989.71%-38.88%+529.19%+61.63%-50.60%+56.76%-55.24%+25.78%----100.00%-+351.00%+20.52%-45.28%+16.79%-22.75%+8.48%+465.86%-86.90%
Cost of Revenue--1.47K128.07K83.19K--148.85K324.22K111.16K116.31K--88.79K047.72K99.94K161.73K78.75K93.60K80.44K101.44K501.16K86.31K
Gross Profit4.48K2.39K526-26.63K-21.20K390.07K630.46K162.56K163.95K107.32K158.49K--160.63K0-19.93K25.42K-10.66K3.91K2.94K-5.87K-20.55K-43.41K-26.32K
Gross Margin100.00%100.00%26.39%-26.26%-34.19%100.00%100.00%52.20%33.58%49.12%57.68%--64.40%--71.69%20.28%-7.05%4.73%3.04%-7.87%-25.40%-9.48%-43.89%
Operating Expense-10.84K20.46K-980.70K-2.56M-1.96M2.20M-2.41M1.97M-1.08M-1.26M-1.22M--1.34M2.68M-2.35M-2.56M2.05M2.26M1.65M1.94M1.34M646.90K478.32K
Operating Income15.32K-18.08K981.23K2.53M1.94M-1.81M3.05M-1.80M1.24M1.36M1.38M1.56M310.32K-1.18M-2.68M2.33M2.59M-2.07M-2.26M-1.65M-1.94M-1.36M-690.31K-504.64K
Operating Margin342.03%-757.71%49233.62%2495.61%3130.85%-463.98%483.00%-579.19%254.81%623.96%502.96%---473.09%-8383.57%2062.89%-1366.95%-2733.79%-1710.67%-2607.24%-1685.78%-150.81%-841.30%
EBITDA-15.32K-18.08K-966.68K-2.48M-1.93M-1.80M-3.02M-1.78M-1.22M-1.35M-1.37M-153.43K-310.32K---2.35M-2.57M-2.05M-2.26M-1.65M-1.92M-1.32M-653.05K-
EBITDA Margin-342.03%-757.71%-48503.61%-2446.21%-3106.89%-460.41%-479.04%-571.84%-250.90%-616.14%-497.33%-----8470.77%-2050.48%-1360.04%-2729.19%-1705.46%-2570.63%-1630.02%-142.67%-
Net Income-15.32K-200.26K-1.01M-2.77M-1.98M-1.81M-3.04M-2.06M-1.76M-2.15M-2.49M7.91M-389.08K-1.75M0-4.01M-2.56M-2.12M-2.38M-1.61M-1.95M-1.57M-770.69K-552.45K
Net Income Margin-342.03%-8393.08%-50638.03%-2733.00%-3198.82%-463.34%-482.56%-662.43%-360.16%-982.07%-907.23%---701.56%--14411.21%-2046.12%-1404.81%-2882.67%-1670.71%-2618.34%-1943.53%-168.37%-921.00%
R&D--264.37K260.01K261.99K604.31K894.23K746.35K598.23K616.49K458.69K-------------
R&D as % of Total Revenue--13264.78%256.33%422.60%154.93%141.84%239.67%122.54%282.17%166.92%-------------
Interest Expense--27.99K---12.32K259.20K514.29K782.42K1.11M1.41M134.31K0056.63K61.23K28.52K5001.18K1.38K1.00K9732.23K
Interest Expense % of Total Revenue--1404.42%---1.95%83.23%105.35%358.12%404.27%--0.00%-203.75%48.85%18.88%0.60%1.23%1.85%1.24%0.21%3.72%

Balance Sheet

Currency: CAD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-09-302014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-31
Total Assets345.55K171.58K1.31M392.07K354.63K530.74K211.28K182.84K168.42K91.25K127.71K508.96K-6.52M2.56M1.71M1.14M601.12K553.55K504.81K528.28K819.51K331.43K
Total Liabilities8.00K34.28K247.35K642.39K842.41K589.78K1.08M2.97M4.70M6.73M9.24M1.21M-3.86M1.63M978.91K475.73K469.73K277.75K661.05K618.52K867.11K948.40K
Total Equity337.55K137.29K1.06M-250.32K-487.78K-59.05K-866.86K-2.79M-4.53M-6.64M-9.12M-705.48K-2.66M928.71K726.98K664.22K131.39K275.79K-156.24K-90.24K-47.60K-616.97K
Cash343.77K169.15K916.47K131.43K245.92K304.48K84.03K5.10K10.62K10.19K7.50K2.67K-151984.66K1.30M805.79K356.47K275.05K1007.37K30.71K175.28K
Total Debt------776.33K2.71M4.41M6.46M8.88M1.02M--1.27M693.85K300.43K48.80K-45.78K-60.00K178.63K
Net Debt-343.77K-169.15K-916.47K-131.43K-245.92K-304.48K692.29K2.71M4.40M6.45M8.87M1.02M--285.34K-609.15K-505.36K-307.67K-275.05K45.68K-7.37K29.29K3.36K

Cash Flow

Currency: CAD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-09-302014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Operating Cash Flow-10.36K-174.62K-875.87K-1.72M-1.52M-2.00M-2.99M-1.75M-1.18M-1.26M-1.31M-1.15M-291.49K-1.10M-1.42M-2.11M-2.26M-1.51M-2.05M-1.24M-1.52M-1.04M-166.09K-264.69K
Investing Cash Flow--------------6.45K-4.47K-6.21K-1.71K-28.18K-28.18K-110.48K-110.48K-4.75K-4.75K-
Financing Cash Flow182.49K-1.75M989.03K1.63M2.07M2.82M1.68M1.19M1.27M1.30M1.66M1.82M507.39K1.66M2.45M1.76M1.07M1.99M965.97K1.64M1.17M315.41K258.62K
Capital Expenditure0094.16K30.73K6.60K24.54K54.24K1922.93K4.17K1.06K006.45K4.47K1.49K1.71K28.18K28.18K110.48K110.48K107.43K4.75K0
Free Cash Flow-10.36K-174.62K-970.03K-1.75M-1.53M-2.02M-3.05M-1.76M-1.18M-1.27M-1.31M-1.15M-291.49K---2.11M-2.26M-1.51M-2.07M-1.24M-1.63M-1.15M-170.84K-264.69K
FCF to OCF100.00%100.00%110.75%101.79%100.43%101.23%101.81%100.01%100.25%100.33%100.08%100.00%100.00%--100.07%100.08%100.00%101.38%100.00%107.26%110.32%102.86%100.00%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate---------------------------------
EPS Actual-0.04-0.02-0.01-0.04-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.00-0.01-0.01-0.01-0.01-0.01-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Surprise---------------------------------
Timing---------------------------------

Key Statistics & Ratios

Market Cap892.12K
Enterprise Value1.10M
Trailing P/E0.00
Forward P/E0.00
Price / Sales29.75
Price / Book20.28
EPS0.00
Book Value-0.005
Revenue (TTM)59.98K
Gross Profit (TTM)-102.95K
EBITDA-532.61K
Profit Margin0.00%
Operating Margin-3430.41%
Return on Equity-611.39%
Return on Assets-175.93%
Shares Outstanding178.42M
Shares Float175.69M
Beta0.82
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 18, 20131:30